TY  - GEN
AU  - Christensen,Rasmus M
AU  - Juhl,Christian R
AU  - Torekov,Signe S
TI  - Benefit-Risk Assessment of Obesity Drugs: Focus on Glucagon-like Peptide-1 Receptor Agonists
SN  - 1179-1942
PY  - 2020///0303
KW  - Animals
KW  - Glucagon-Like Peptides
KW  - adverse effects
KW  - Humans
KW  - Hypoglycemic Agents
KW  - Liraglutide
KW  - Obesity
KW  - drug therapy
KW  - Randomized Controlled Trials as Topic
KW  - Risk Assessment
KW  - Glucagon-Like Peptide-1 Receptor Agonists
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
UR  - https://doi.org/10.1007/s40264-019-00812-7
ER  -